Medical Research News

RSS

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Stunning scientific images of blood, brain, bacteria, viruses and more, enlarged by as much as 50,000 times, are on display in an exhibit called "Life: Magnified," on view through November 2014 at Washington Dulles International Airport's Gateway Gallery.

9 Jun 2014

Merck enters into definitive agreement with Idenix

Merck, known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc., today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per share in cash.

9 Jun 2014

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

Rubicon Genomics, Inc., today announced that it signed agreements with seven distributors in Europe to expand the availability of its leading DNA library preparation products, including ThruPLEX®-FD Prep Kit and PicoPLEX™ DNA-seq Kit for use with Illumina® next-generation sequencing (NGS) systems and PicoPLEX™ WGA Kit for use on arrays, and to prepare for new product launches planned for the coming months.

9 Jun 2014

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

As part of its ongoing research to better understand the complexities of the human brain, the Allen Institute for Brain Science is embarking on the first effort to map connectivity patterns across the whole brain in mouse models of Alzheimer's disease, through its recent award of a $3.4 million grant over five years from the National Institute on Aging of the National Institutes of Health.

9 Jun 2014

Certain molecules in seminal fluid indicate presence and severity of prostate cancer

Improved diagnosis and management of one of the most common cancers in men - prostate cancer - could result from research at the research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.

9 Jun 2014

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Mylan Inc. today announced that it has launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials, which is the generic version of Bristol-Myers Squibb's Paraplatin® Injection.

9 Jun 2014

Researchers identify critical weakness of invasive cancer cells

Metastatic cancer cells, which can migrate from primary tumors to seed new malignancies, have thus far been resistant to the current arsenal of anticancer drugs.

9 Jun 2014

Research finding paves way for targeted approaches to treating cancer patients

Twelve years ago, UNC School of Medicine researcher Brian Strahl, PhD, found that a protein called Set2 plays a role in how yeast genes are expressed - specifically how DNA gets transcribed into messenger RNA. Now his lab has found that Set2 is also a major player in DNA repair, a complicated and crucial process that can lead to the development of cancer cells if the repair goes wrong.

9 Jun 2014

Studies stress the importance of vitamin D intake during first year of life

Everyone seems to agree that vitamin D is important throughout life. This is certainly as true in the first year of life as it is later on.

9 Jun 2014

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).

9 Jun 2014

Accelera signs agreement to complete preclinical studies of Cellectis' UCART19

Cellectis, a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed an agreement to complete the preclinical studies of Cellectis' advanced product candidate, UCART19.

9 Jun 2014

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.

9 Jun 2014

New class of genetic switches gives clues on stem cell development

Case Western Reserve researchers have discovered landmarks within pluripotent stem cells that guide how they develop to serve different purposes within the body.

9 Jun 2014

New mathematical models seem to explain processing in medial temporal lobes

When it comes to familiarity, a slew of memories including seemingly unrelated ones can come flooding into the brain, according to mathematical theories called global similarity models.

9 Jun 2014

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.

9 Jun 2014

Only 20% of health policy researchers use social media for communication, shows survey

Though Twitter boats 645 million users across the world, only 14 percent of health policy researchers reported using Twitter - and approximately 20 percent used blogs and Facebook - to communicate their research findings over the past year, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

9 Jun 2014

NASA astronaut to give presentation at NIH in Bethesda, Maryland

NASA astronaut Mike Hopkins, recently returned from living and working aboard the International Space Station, will give an open-media, presentation Tuesday, June 10, at the National Institutes of Health (NIH) in Bethesda, Maryland.

9 Jun 2014

Researchers examine link between residential environment and preterm delivery among African Americans

High levels of racial disparities in preterm delivery exist, with African Americans having higher rates than non-Hispanic whites.

9 Jun 2014

Study defines how our ability to identify spatial acuity varies across the body

"Where does it hurt?" is the first question asked to any person in pain. A new UCL study defines for the first time how our ability to identify where it hurts, called "spatial acuity", varies across the body, being most sensitive at the forehead and fingertips.

9 Jun 2014

Kids at risk for mental disorders experience communication breakdown in brain networks

Attention deficits are central to psychiatric disorders such as schizophrenia or bipolar disorder, and are thought to precede the presentation of the illnesses.

9 Jun 2014

Medical Research News

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Merck enters into definitive agreement with Idenix

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

Certain molecules in seminal fluid indicate presence and severity of prostate cancer

Mylan launches generic version of Bristol-Myers Squibb's Paraplatin Injection

Researchers identify critical weakness of invasive cancer cells

Research finding paves way for targeted approaches to treating cancer patients

Studies stress the importance of vitamin D intake during first year of life

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Accelera signs agreement to complete preclinical studies of Cellectis' UCART19

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

New class of genetic switches gives clues on stem cell development

New mathematical models seem to explain processing in medial temporal lobes

Advances in understanding of genetics of CAD lead to more therapeutic targets

Only 20% of health policy researchers use social media for communication, shows survey

NASA astronaut to give presentation at NIH in Bethesda, Maryland

Researchers examine link between residential environment and preterm delivery among African Americans

Study defines how our ability to identify spatial acuity varies across the body

Kids at risk for mental disorders experience communication breakdown in brain networks

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News